# STAT4

## Overview
STAT4 (signal transducer and activator of transcription 4) is a gene that encodes a transcription factor belonging to the STAT protein family, which plays a pivotal role in the JAK-STAT signaling pathway. The STAT4 protein is primarily expressed in immune cells and is crucial for mediating responses to cytokines such as interleukin-12 (IL-12), interleukin-23 (IL-23), and type I interferons (IFNs). These cytokines are essential for the differentiation of T helper 1 (Th1) cells, a subset of CD4+ T helper cells, and for the regulation of immune responses (Seif2017The; O’Shea2011Genomic). STAT4 is activated through tyrosine phosphorylation, which allows it to translocate to the nucleus and regulate gene expression by binding to specific DNA sequences. This regulation is critical for the expression of genes involved in immune responses, including the production of interferon-gamma (IFNγ) and other cytokines (O’Shea2011Genomic; Bacon1995Interleukin). The gene's polymorphisms have been linked to various autoimmune diseases, highlighting its clinical significance in immune regulation (Yan2014Association; Remmers2007STAT4and).

## Structure
STAT4 is a member of the STAT protein family and plays a crucial role in the JAK-STAT signaling pathway. The protein is composed of several distinct domains, each contributing to its function. The N-terminal domain facilitates dimerization of inactivated STATs and promotes nuclear translocation (Yang2020STAT4:). The helical coiled-coil domain provides a hydrophilic surface for binding regulatory factors, while the DNA-binding domain interacts with enhancers of the GAS family (Yang2020STAT4:). The linker domain is involved in the DNA binding process, and the Src homology 2 (SH2) domain specifically binds to cytokine receptors following tyrosine phosphorylation (Yang2020STAT4:). The C-terminal transactivation domain is responsible for activating transcription (Yang2020STAT4:).

STAT4 undergoes alternative splicing, resulting in isoforms such as STAT4α and STAT4β. STAT4α is associated with higher IFN-γ production, while STAT4β shows more vigorous proliferation in response to IL-12 stimulation (Yang2020STAT4:). The STAT4b isoform is 44 amino acids shorter at the C-terminus due to an inserted exon, affecting its structure and function (Lim2006Structure). Phosphorylation, particularly at tyrosine residues, is a key post-translational modification necessary for STAT4 activation and function (Lim2006Structure).

## Function
STAT4 (signal transducer and activator of transcription 4) is a transcription factor primarily expressed in immune cells and the testis. It plays a crucial role in mediating responses to cytokines such as interleukin-12 (IL-12), interleukin-23 (IL-23), and type I interferons (IFNs), which are essential for the differentiation of T helper 1 (Th1) cells, a subset of CD4+ T helper cells (Seif2017The; O’Shea2011Genomic). STAT4 is activated through tyrosine phosphorylation, a process initiated by cytokine signaling, which allows it to translocate to the nucleus and regulate gene expression (Bacon1995Interleukin).

In the nucleus, STAT4 binds to specific DNA sequences, influencing the transcription of genes involved in immune responses. It is a major regulator of interferon-gamma (IFNγ) expression, a key cytokine in immune responses, particularly in innate immune cells like natural killer (NK) cells (O’Shea2011Genomic). STAT4 also regulates the expression of other cytokines, such as IL-10 and IL-21, which are expressed by multiple T cell subsets (O’Shea2011Genomic). Through these activities, STAT4 contributes to the activation of monocytes and the production of IFNγ, playing a critical role in the body's defense against pathogens and in maintaining immune homeostasis (Korman2008STAT4:).

## Clinical Significance
Mutations and polymorphisms in the STAT4 gene are associated with several autoimmune diseases. The single nucleotide polymorphism (SNP) rs7574865 in the STAT4 gene is linked to an increased risk of autoimmune thyroid diseases, particularly Graves' disease, in a Chinese population (Yan2014Association). This SNP is also associated with rheumatoid arthritis and systemic lupus erythematosus, with studies showing a higher minor allele frequency in patients compared to controls, indicating increased susceptibility (Remmers2007STAT4and). The presence of the rs7574865 polymorphism is associated with higher STAT4 expression levels in systemic lupus erythematosus patients, suggesting it may influence disease activity through dysregulation of the Th1 and Th17 pathways (Yan2014Association).

In systemic sclerosis, STAT4 has been identified as a genetic susceptibility factor, with its deficiency in mice leading to protection against inflammation-driven fibrosis (Avouac2011Inactivation). The gene is also implicated in primary Sjögren's syndrome, where the T allele of rs7574865 is more prevalent in patients, suggesting a genetic predisposition (Korman2008Variant). These findings underscore the role of STAT4 in mediating immune responses and its clinical significance in autoimmune diseases.

## Interactions
STAT4 interacts with various proteins and nucleic acids, playing a crucial role in immune signaling pathways. It is activated by cytokines such as IL-12, leading to its phosphorylation and dimerization, which allows it to bind DNA and regulate gene expression (Yang2020STAT4:). STAT4 forms homodimers and heterodimers, such as STAT4-STAT4 and STAT3-STAT4, which are involved in Th17 differentiation and chronic inflammation (Yang2020STAT4:). 

STAT4 interacts with Janus kinases (Jak1 and Jak2), which phosphorylate STAT4, enabling it to bind to the gamma interferon activation site (GAS) element of the IRF-1 gene (Yamamoto1994Stat4). This interaction is crucial for its function in early myeloid differentiation and immune response regulation (Yamamoto1994Stat4).

STAT4 also interacts with activator protein 1 (AP1) and other transcription factors, influencing the expression of genes involved in immune responses (Yang2020STAT4:). Negative regulators such as SOCS3 and PIAS4 modulate STAT4 activity by inhibiting its phosphorylation and gene activation capabilities (Yang2020STAT4:; Gong2020Identification). These interactions highlight STAT4's central role in immune regulation and its involvement in various signaling pathways.


## References


[1. (Yan2014Association) Ni Yan, Shuai Meng, Jiaozhen Zhou, Jian Xu, Fatuma Muhali, Wenjuan Jiang, Liangfeng Shi, Xiaohong Shi, and Jinan Zhang. Association between stat4 gene polymorphisms and autoimmune thyroid diseases in a chinese population. International Journal of Molecular Sciences, 15(7):12280–12293, July 2014. URL: http://dx.doi.org/10.3390/ijms150712280, doi:10.3390/ijms150712280. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms150712280)

[2. (Lim2006Structure) Cheh Peng Lim and Xinmin Cao. Structure, function, and regulation of stat proteins. Molecular BioSystems, 2(11):536, 2006. URL: http://dx.doi.org/10.1039/b606246f, doi:10.1039/b606246f. This article has 255 citations and is from a peer-reviewed journal.](https://doi.org/10.1039/b606246f)

[3. (Gong2020Identification) Xiaowei Gong, Qiwei Chen, and Fuying Zheng. Identification of protein inhibitor of activated stat 4, a novel host interacting partner that involved in bovine viral diarrhea virus growth. Virology Journal, April 2020. URL: http://dx.doi.org/10.1186/s12985-020-01330-0, doi:10.1186/s12985-020-01330-0. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12985-020-01330-0)

[4. (Korman2008Variant) B D Korman, M I Alba, J M Le, I Alevizos, J A Smith, N P Nikolov, D L Kastner, E F Remmers, and G G Illei. Variant form of stat4 is associated with primary sjögren’s syndrome. Genes &amp; Immunity, 9(3):267–270, February 2008. URL: http://dx.doi.org/10.1038/gene.2008.1, doi:10.1038/gene.2008.1. This article has 141 citations.](https://doi.org/10.1038/gene.2008.1)

[5. (O’Shea2011Genomic) John J. O’Shea, Riitta Lahesmaa, Golnaz Vahedi, Arian Laurence, and Yuka Kanno. Genomic views of stat function in cd4+ t helper cell differentiation. Nature Reviews Immunology, 11(4):239–250, March 2011. URL: http://dx.doi.org/10.1038/nri2958, doi:10.1038/nri2958. This article has 244 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri2958)

[6. (Yamamoto1994Stat4) Koh Yamamoto, Frederick W. Quelle, William E. Thierfelder, Brent L. Kreider, Debra J. Gilbert, Nancy A. Jenkins, Neal G. Copeland, Olli Silvennoinen, and James N. Ihle1. Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Molecular and Cellular Biology, 14(7):4342–4349, July 1994. URL: http://dx.doi.org/10.1128/mcb.14.7.4342-4349.1994, doi:10.1128/mcb.14.7.4342-4349.1994. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.14.7.4342-4349.1994)

[7. (Korman2008STAT4:) Benjamin D. Korman, Daniel L. Kastner, Peter K. Gregersen, and Elaine F. Remmers. Stat4: genetics, mechanisms, and implications for autoimmunity. Current Allergy and Asthma Reports, 8(5):398–403, September 2008. URL: http://dx.doi.org/10.1007/s11882-008-0077-8, doi:10.1007/s11882-008-0077-8. This article has 141 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11882-008-0077-8)

[8. (Remmers2007STAT4and) Elaine F. Remmers, Robert M. Plenge, Annette T. Lee, Robert R. Graham, Geoffrey Hom, Timothy W. Behrens, Paul I.W. de Bakker, Julie M. Le, Hye-Soon Lee, Franak Batliwalla, Wentian Li, Seth L. Masters, Matthew G. Booty, John P. Carulli, Leonid Padyukov, Lars Alfredsson, Lars Klareskog, Wei V. Chen, Christopher I. Amos, Lindsey A. Criswell, Michael F. Seldin, Daniel L. Kastner, and Peter K. Gregersen. Stat4and the risk of rheumatoid arthritis and systemic lupus erythematosus. New England Journal of Medicine, 357(10):977–986, September 2007. URL: http://dx.doi.org/10.1056/nejmoa073003, doi:10.1056/nejmoa073003. This article has 786 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/nejmoa073003)

[9. (Yang2020STAT4:) Chou Yang, Haoming Mai, Jinxin Peng, Bin Zhou, Jinlin Hou, and Deke Jiang. Stat4: an immunoregulator contributing to diverse human diseases. International Journal of Biological Sciences, 16(9):1575–1585, 2020. URL: http://dx.doi.org/10.7150/ijbs.41852, doi:10.7150/ijbs.41852. This article has 70 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.41852)

[10. (Avouac2011Inactivation) Jérôme Avouac, Barbara G. Fürnrohr, Michal Tomcik, Katrin Palumbo, Pawel Zerr, Angelika Horn, Clara Dees, Alfiya Akhmetshina, Christian Beyer, Oliver Distler, Georg Schett, Yannick Allanore, and Jörg H. W. Distler. Inactivation of the transcription factor stat-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. Arthritis &amp; Rheumatism, 63(3):800–809, February 2011. URL: http://dx.doi.org/10.1002/art.30171, doi:10.1002/art.30171. This article has 65 citations.](https://doi.org/10.1002/art.30171)

[11. (Seif2017The) Farhad Seif, Majid Khoshmirsafa, Hossein Aazami, Monireh Mohsenzadegan, Gholamreza Sedighi, and Mohammadali Bahar. The role of jak-stat signaling pathway and its regulators in the fate of t helper cells. Cell Communication and Signaling, June 2017. URL: http://dx.doi.org/10.1186/s12964-017-0177-y, doi:10.1186/s12964-017-0177-y. This article has 562 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12964-017-0177-y)

[12. (Bacon1995Interleukin) C M Bacon, E F Petricoin, J R Ortaldo, R C Rees, A C Larner, J A Johnston, and J J O’Shea. Interleukin 12 induces tyrosine phosphorylation and activation of stat4 in human lymphocytes. Proceedings of the National Academy of Sciences, 92(16):7307–7311, August 1995. URL: http://dx.doi.org/10.1073/pnas.92.16.7307, doi:10.1073/pnas.92.16.7307. This article has 341 citations.](https://doi.org/10.1073/pnas.92.16.7307)